Literature DB >> 10798774

Histopathological features of hepatitis C in renal transplant candidates [see comment].

P Martin1, D Carter, F Fabrizi, V Dixit, A J Conrad, L Artinian, V Peacock, S Han, A Wilkinson, C R Lassman, G Danovitch.   

Abstract

BACKGROUND: Although hepatitis C virus (HCV) infection is common in renal transplant candidates, its clinical significance remains unclear in this population. Little detailed information is available about the histological severity of HCV infection in these patients. We evaluated the liver biopsy features of chronic HCV in a large population of renal transplant candidates and investigated associations between histopathological changes and host- and virus-related factors.
METHODS: Thirty-seven patients seropositive for anti-HCV with chronic renal failure (CRF) referred to UCLA Medical Center for kidney or kidney/liver transplantation during the period 1992-1997 were included. HCV genotype and viral load were measured. A multivariate analysis by logistic regression model was performed: age, gender, race, HCV load and genotype, CRF level, aspartate and alanine aminotransferase activity, duration of HCV infection, underlying nephropathy, and alcohol abuse were independent variables; liver histology score was assumed a dependent variable.
RESULTS: Liver disease was present in all HCV-infected patients. Logistic regression analysis revealed that histological damage was (P = 0.0017) independently associated with the CRF level; the severity of liver disease, as shown by univariate analysis, being significantly higher in CRF patients not requiring dialysis than among dialysis population. All patients on dialysis showed mild or moderate necroinflammatory activity; the majority (22/28 = 79%) of these individuals had fibrosis, three (3/28 = 11%) dialysis patients had established cirrhosis. Thirty-one (84%) of 37 patients were tested by polymerase chain reaction, 25 (81%) patients had detectable HCV RNA in serum, the mean HCV load among viremic patients was 10.9x10(5) copies/ ml. The most frequent HCV genotypes were la (8/24 = 33%) and 1b (7/24 = 29%), followed by genotype 2b (3/24 = 12%).
CONCLUSIONS: Pathological changes on liver biopsy were observed in all HCV-infected patients awaiting renal transplantation. The severity of histologic damage observed on liver biopsy was less in dialysis than predialysis CRF patients. All dialysis patients had mild or moderate necroinflammatory activity; fibrosis was frequent with 11% of them having cirrhosis. The HCV viral load was rather low; no relationship between liver histology changes and virological features of HCV or aminotransferase activity was apparent. Further studies with repeat liver biopsies after kidney transplantation to observe the evolution of HCV-related liver disease after immunosuppressive therapy are indicated. We suggest including liver biopsy in the evaluation of the HCV-infected renal transplant candidate.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10798774     DOI: 10.1097/00007890-200004150-00045

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  16 in total

Review 1.  Management of hepatitis C in patients with chronic kidney disease.

Authors:  Mohammad A B Al-Freah; Zeino Zeino; Michael A Heneghan
Journal:  Curr Gastroenterol Rep       Date:  2012-02

Review 2.  Hepatitis C infection in hemodialysis patients: A review.

Authors:  Digdem Ozer Etik; Serkan Ocal; Ahmet Sedat Boyacioglu
Journal:  World J Hepatol       Date:  2015-04-28

Review 3.  Hepatitis C and kidney disease: An overview and approach to management.

Authors:  Ahmad Najib Azmi; Soek-Siam Tan; Rosmawati Mohamed
Journal:  World J Hepatol       Date:  2015-01-27

4.  Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis.

Authors:  Ioan Sporea; Alina Popescu; Roxana Sirli; Ovidiu Golea; Camelia Totolici; Mirela Danila; Corina Vernic
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

5.  Effect of kidney transplantation on outcomes among patients with hepatitis C.

Authors:  David Roth; Jeffrey J Gaynor; K Rajender Reddy; Gaetano Ciancio; Junichiro Sageshima; Warren Kupin; Giselle Guerra; Linda Chen; George W Burke
Journal:  J Am Soc Nephrol       Date:  2011-05-05       Impact factor: 10.121

6.  End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection.

Authors:  F M Aslinia; S K Wasan; A L Mindikoglu; O A Adeyemo; B Philosophe; C Drachenberg; C D Howell
Journal:  J Viral Hepat       Date:  2012-01-16       Impact factor: 3.728

7.  Hepatitis C infection and chronic renal diseases.

Authors:  Aline Gonzalez Vigani
Journal:  Hepatol Int       Date:  2012-03-15       Impact factor: 6.047

8.  Hepatitis C Virus Infection in Patients with End-Stage Renal Disease: A Study from a Tertiary Care Centre in India.

Authors:  Anil Arora; Naresh Bansal; Praveen Sharma; Vikas Singla; Varun Gupta; Pankaj Tyagi; Manish Malik; Ashish Kumar
Journal:  J Clin Exp Hepatol       Date:  2015-04-29

9.  Hepatitis C is less aggressive in hemodialysis patients than in nonuremic patients.

Authors:  Jose Eduardo Trevizoli; Raissa de Paula Menezes; Lara Franciele Ribeiro Velasco; Regina Amorim; Mauro Birche de Carvalho; Liliana Sampaio Mendes; Columbano Junqueira Neto; José Roberto de Deus Macedo; Francisco de Assis; Rocha Neves
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 8.237

10.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.